MOH — authorised 28 January 2016
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
MOH authorised Zepatier on 28 January 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 28 January 2016.
MERCK SHARP DOHME holds the Israeli marketing authorisation.